Performance of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies in South Africa.
Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) has been identified as the causative agent for causing the clinical syndrome of COVID -19. Accurate detection of SARS-CoV-2 infection is not only important for management of infected individuals but also to break the chain of transmission....
Main Authors: | Maemu P Gededzha, Nakampe Mampeule, Sarika Jugwanth, Nontobeko Zwane, Anura David, Wendy A Burgers, Jonathan M Blackburn, Jurette S Grove, Jaya A George, Ian Sanne, Lesley Scott, Wendy Stevens, Elizabeth S Mayne |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0252317 |
Similar Items
-
Validation of Roche immunoassay for severe acute respiratory coronavirus 2 in South Africa
by: Jurette S. Grove, et al.
Published: (2021-07-01) -
Evaluation the Efficacy of ELISA IgG, IgM and IgA Tests for Diagnosis of Helicobacter pylori
by: Hogir Mohammed Shukri Saadi, et al.
Published: (2018-09-01) -
IgA in IgA nephropathy
by: Layward, Lorna
Published: (1992) -
IgA glycosylation in IgA nephropathy
by: Allen, Alice
Published: (1995) -
Diagnostic accuracy of Fusobacterium nucleatum IgA and IgG ELISA test in colorectal cancer
by: Melike Kurt, et al.
Published: (2021-01-01)